Beuschlein Named Editor-in-Chief of European Journal of Endocrinology

Felix Beuschlein_TAA 2024 Award

Endocrine Society member and 2024 recipient of the Transatlantic Alliance Award, Felix Beuschlein, MD, has been named editor-in-chief of the European Society of Endocrinology (ESE)’s flagship journal, the European Journal of Endocrinology (EJE).

He will assume his post in May 2024 when the current editor-in-chief and fellow Endocrine Society member, Wiebke Arlt, MD, DSc, FRCP, FMedSci, steps down.

Professor Philippe Chanson, chair of ESE’s Publications and Communications Committee said, “I am delighted that Felix will be the next Editor in Chief of ESE’s flagship journal and will continue to build on the strong foundations laid by his predecessors. Felix’s internationally recognized work, his large network and his collaborative and thorough approach to research means EJE is in good hands.”

Beuschlein is professor of internal medicine/endocrinology and director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Zurich in Switzerland. He received his medical degree from the School of Medicine at the University of Würzburg and completed his medical training in Freiburg, both in Germany. For postdoctoral studies he joined the University of Michigan in Ann Arbor. Following a professorship for Endocrine Research at the University of Munich in 2017, he was recently elected for a chair position at the University of Zurich.

In November, Beuschlein was awarded the ‘Transatlantic Alliance Award’ by ESE and the Endocrine Society which recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic – in
Europe and the United States.

“I am thrilled and honored to take on this position within the EJE team to continue on a development of the journal towards its leading position reflecting clinical and translation endocrinology at large,” Beuschlein says.

Arlt, director of the MRC Laboratory of Medical Sciences (LMS) and professor of transdisciplinary medicine, Imperial College London, UK, has been editor-in-chief since January 2019, when she succeeded Professor Hans Romijn. Since then, she has taken the journal to its highest ever Impact Factor of 6.664 (June 2021) and number 20 out of 145 in the JCR list of Endocrinology and Metabolism research journals in terms of Impact Factor, underpinning the leading role of ESE in fostering exchange and scientific discourse and promoting endocrinology.

Wiebke Arlt, MD, DSc, FRCP, FMedSci

She has built a strong and diverse Editorial Board with gender parity. Arlt has also introduced the ‘EJE Rising Stars’ in 2022, fostering and developing editorial board members of the future. The second EJE Rising Stars cohort will be announced shortly.

Arlt, a recipient of the Endocrine Society’s 2019 Outstanding Clinical Investigator Award, was elected as ESE’s president elect in May 2023 and will assume the role of ESE President in May 2025 when the current president and Endocrine Society member, Jérôme Bertherat, MD, PhD, steps down.

“Felix Beuschlein is an internationally leading endocrinologist with a track record of collaboration and innovation,” Arlt says. “I am looking forward to working with him over the transition period in the coming months and I am delighted that EJE will continue to be in very safe hands.”

“On behalf of ESE’s members I am pleased to have such an excellent successor to our current Editor in Chief Wiebke Arlt to take the Journal into the next phase of its development,” Bertherat says. “The ESE Executive Committee and I look forward to working with him over the years ahead.”

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in